Pulmonx Corp (LUNG) Stock Price, Quote & News

Company Profile

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography a...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 364 0400

Website: pulmonx.com

Address:

700 Chesapeake Drive, Redwood City, United States

beachsidefreddy May. 13 at 4:15 PM

$LUNG HOLD ON!!

0 · Reply

beachsidefreddy May. 13 at 12:23 PM

$LUNG EXACT WORDS FROM FRENCH AT CC YESTERDAY: "commenced convert one trial presented and will SOON BE PUBLISHED"

1 · Reply

beachsidefreddy May. 12 at 6:28 PM

$LUNG AERISEAL!!!

0 · Reply

beachsidefreddy May. 12 at 6:05 PM

$LUNG HOLD ON YOU RODENTS!!!!

0 · Reply

beachsidefreddy May. 12 at 4:39 PM

$LUNG someone bought 219,000 shares of the stock yesterday at 9:45 AM right here

0 · Reply

beachsidefreddy May. 12 at 3:35 PM

$LUNG he talked BILLIONS OF DOLLARS in potential

0 · Reply

beachsidefreddy May. 12 at 2:42 PM

$LUNG CC at 11:15 EST

0 · Reply

beachsidefreddy May. 12 at 1:02 PM

$LUNG. SHORTS

0 · Reply

beachsidefreddy May. 11 at 8:02 PM

$LUNG NASTY CLOSE!!! GO!!!

0 · Reply

beachsidefreddy May. 11 at 6:03 PM

$LUNG LUNG REDWOOD CITY, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be presenting at the Bank of America Securities 2026 Health Care Conference in Las Vegas on Tuesday, May 12, 2026, at 8:15 AM PT / 11:15 AM ET.

0 · Reply

Pulmonx Transcript: Bank of America Global Healthcare Conference 2026

2026-04-29T20:32:57.000Z - 14 days ago

Pulmonx reports Q1 EPS (33c), consensus (33c)

2026-04-29T20:30:26.000Z - 14 days ago

Pulmonx backs FY26 revenue view $90M-$92M, consensus $90.87M

Apr 29, 2026, 4:30 PM EDT - 14 days ago

Pulmonx Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:05 PM EDT - 14 days ago

Pulmonx Reports First Quarter 2026 Financial Results

Apr 28, 2026, 4:05 PM EDT - 15 days ago

Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference

Apr 15, 2026, 4:05 PM EDT - 4 weeks ago

Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026

2026-03-05T11:42:24.000Z - 2 months ago

Pulmonx price target lowered to $5 from $6 at Canaccord

2026-03-04T21:39:51.000Z - 2 months ago

Pulmonx reports Q4 EPS (25c), consensus (38c)

2026-03-04T21:38:59.000Z - 2 months ago

Pulmonx sees FY26 revenue $90M-$92M, consensus $94.23M

Mar 4, 2026, 4:30 PM EST - 2 months ago

Pulmonx Earnings Call Transcript: Q4 2025

Mar 4, 2026, 4:06 PM EST - 2 months ago

Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 4, 2026, 4:05 PM EST - 2 months ago

Pulmonx Announces Closing of up to $60 Million Credit Facility

Feb 20, 2026, 8:00 AM EST - 2 months ago

Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Dec 3, 2025, 4:05 PM EST - 5 months ago

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

2025-11-12T21:50:46.000Z - 6 months ago

Pulmonx reports Q3 EPS (34c), consensus (42c)

2025-11-12T21:50:40.000Z - 6 months ago

Pulmonx cuts FY25 revenue view to $89M-$90M from $90M-$92M

Nov 12, 2025, 4:30 PM EST - 6 months ago

Pulmonx Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:05 PM EST - 6 months ago

Pulmonx Reports Third Quarter 2025 Financial Results

2025-10-28T12:45:40.000Z - 7 months ago

Pulmonx price target lowered to $4 from $8 at Lake Street

2025-10-27T20:16:44.000Z - 7 months ago

Pulmonx CEO Steve Williamson resigns, Glen French succeeds

2025-10-27T20:16:21.000Z - 7 months ago

Pulmonx reports preliminary Q3 revenue $21.5M, consensus $20.78M

Oct 27, 2025, 4:05 PM EDT - 7 months ago

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

Oct 15, 2025, 4:05 PM EDT - 7 months ago

Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025

2025-09-26T21:25:28.000Z - 8 months ago

Pulmonx files $200M mixed securities shelf

Sep 4, 2025, 4:30 PM EDT - 8 months ago

Pulmonx Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 26, 2025, 4:05 PM EDT - 9 months ago

Pulmonx to Participate in September Investor Conferences

Aug 12, 2025, 10:00 AM EDT - 9 months ago

Pulmonx Transcript: Canaccord Genuity’s 45th Annual Growth Conference

2025-07-31T13:07:02.000Z - 10 months ago

Pulmonx price target lowered to $8 from $12 at Lake Street

2025-07-31T09:10:37.000Z - 10 months ago

Pulmonx downgraded to Neutral from Overweight at Piper Sandler

Jul 30, 2025, 4:30 PM EDT - 10 months ago

Pulmonx Earnings Call Transcript: Q2 2025

2025-07-30T20:17:04.000Z - 10 months ago

Pulmonx reports Q2 EPS (38c), consensus (40c)

2025-07-30T20:15:53.000Z - 10 months ago

Pulmonx cuts FY25 revenue view to $90M-$92M from $96M-$98M, consensus $96.95M

Jul 30, 2025, 4:05 PM EDT - 10 months ago

Pulmonx Reports Second Quarter 2025 Financial Results

Jul 16, 2025, 4:05 PM EDT - 10 months ago

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

Jun 11, 2025, 10:00 AM EDT - 1 year ago

Pulmonx Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

2025-05-22T10:41:01.000Z - 1 year ago

Pulmonx price target lowered to $4.15 from $6.50 at Citi

May 14, 2025, 12:35 PM EDT - 1 year ago

Pulmonx Transcript: Bank of America 2025 Healthcare Conference

May 1, 2025, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

2025-05-01T11:03:30.000Z - 1 year ago

Pulmonx price target lowered to $9 from $10 at Piper Sandler

2025-05-01T10:56:40.000Z - 1 year ago

Pulmonx price target lowered to $15 from $16 at Canaccord

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Pulmonx Earnings Call Transcript: Q1 2025

2025-04-30T20:21:35.000Z - 1 year ago

Pulmonx reports Q1 EPS (36c), consensus (40c)

2025-04-30T20:20:42.000Z - 1 year ago

Pulmonx backs FY25 revenue view $96M-$98M, consensus $96.98M

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Pulmonx Reports First Quarter 2025 Financial Results

Mar 3, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Glen French to Board of Directors

EDAP

Feb 27, 2025, 11:00 AM EST - 1 year ago

Pulmonx Transcript: Citi’s 2025 Medtech and Life Sciences Access Day

Feb 19, 2025, 4:30 PM EST - 1 year ago

Pulmonx Earnings Call Transcript: Q4 2024

Feb 19, 2025, 4:05 PM EST - 1 year ago

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

Feb 13, 2025, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

Feb 5, 2025, 4:05 PM EST - 1 year ago

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Dec 4, 2024, 12:30 PM EST - 1 year ago

Pulmonx Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 9:10 AM EST - 1 year ago

Pulmonx Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 9:00 AM EST - 1 year ago

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Nov 5, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Stifel 2024 Healthcare Conference

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Pulmonx Earnings Call Transcript: Q3 2024

Oct 16, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

Sep 9, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Sep 5, 2024, 4:30 PM EDT - 1 year ago

Pulmonx Transcript: 2024 Wells Fargo Healthcare Conference

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

Aug 22, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Pulmonx Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Jul 31, 2024, 4:30 PM EDT - 1 year ago

Pulmonx Earnings Call Transcript: Q2 2024

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 10, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Earnings Call Transcript: Q1 2024

May 1, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Reports First Quarter 2024 Financial Results

Apr 10, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 2, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Feb 26, 2024, 8:00 AM EST - 2 years ago

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial

Feb 21, 2024, 4:30 PM EST - 2 years ago

Pulmonx Earnings Call Transcript: Q4 2023

Feb 21, 2024, 4:06 PM EST - 2 years ago

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 21, 2024, 4:05 PM EST - 2 years ago

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

Feb 7, 2024, 4:05 PM EST - 2 years ago

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Nov 29, 2023, 2:00 PM EST - 2 years ago

Pulmonx Transcript: Piper Sandler 35th Annual Healthcare Conference

Nov 15, 2023, 4:05 PM EST - 2 years ago

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

Oct 31, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Participate at Upcoming Investor Conferences

Oct 30, 2023, 4:30 PM EDT - 2 years ago

Pulmonx Earnings Call Transcript: Q3 2023

Oct 30, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Reports Record Third Quarter 2023 Financial Results

Oct 16, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

Oct 10, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Sep 6, 2023, 2:15 PM EDT - 2 years ago

Pulmonx Transcript: Wells Fargo Securities Healthcare Conference 2023

Aug 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Earnings Call Transcript: Q2 2023

Aug 2, 2023, 4:05 PM EDT - 3 years ago

Pulmonx Reports Second Quarter 2023 Financial Results

Jul 26, 2023, 4:05 PM EDT - 3 years ago

Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference

Jul 17, 2023, 8:00 AM EDT - 3 years ago

Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023

May 9, 2023, 6:55 PM EDT - 3 years ago

Pulmonx Transcript: Bank of America Global Healthcare Conference 2023

May 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Earnings Call Transcript: Q1 2023

May 2, 2023, 4:05 PM EDT - 3 years ago

Pulmonx Reports First Quarter 2023 Financial Results

Apr 25, 2023, 4:05 PM EDT - 3 years ago

Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference

Apr 18, 2023, 4:05 PM EDT - 3 years ago

Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023

Mar 2, 2023, 3:30 PM EST - 3 years ago

Pulmonx Transcript: Citi Healthcare & Medtech Conference

Feb 22, 2023, 4:30 PM EST - 3 years ago

Pulmonx Earnings Call Transcript: Q4 2022

Feb 22, 2023, 4:05 PM EST - 3 years ago

Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results

Feb 16, 2023, 4:05 PM EST - 3 years ago

Pulmonx to Present at the Citi 2023 Healthcare Conference

beachsidefreddy May. 13 at 4:15 PM

$LUNG HOLD ON!!

0 · Reply

beachsidefreddy May. 13 at 12:23 PM

$LUNG EXACT WORDS FROM FRENCH AT CC YESTERDAY: "commenced convert one trial presented and will SOON BE PUBLISHED"

1 · Reply

beachsidefreddy May. 12 at 6:28 PM

$LUNG AERISEAL!!!

0 · Reply

beachsidefreddy May. 12 at 6:05 PM

$LUNG HOLD ON YOU RODENTS!!!!

0 · Reply

beachsidefreddy May. 12 at 4:39 PM

$LUNG someone bought 219,000 shares of the stock yesterday at 9:45 AM right here

0 · Reply

beachsidefreddy May. 12 at 3:35 PM

$LUNG he talked BILLIONS OF DOLLARS in potential

0 · Reply

beachsidefreddy May. 12 at 2:42 PM

$LUNG CC at 11:15 EST

0 · Reply

beachsidefreddy May. 12 at 1:02 PM

$LUNG. SHORTS

0 · Reply

beachsidefreddy May. 11 at 8:02 PM

$LUNG NASTY CLOSE!!! GO!!!

0 · Reply

beachsidefreddy May. 11 at 6:03 PM

0 · Reply

beachsidefreddy May. 11 at 5:10 PM

$LUNG we are crossing Rubicon it’s time for war!!!

0 · Reply

beachsidefreddy May. 11 at 3:48 PM

$LUNG we are about to cross the Rubicon!!!!!!!!

0 · Reply

beachsidefreddy May. 11 at 2:07 PM

$LUNG fucking halt it!!!!!

0 · Reply

beachsidefreddy May. 11 at 2:05 PM

$LUNG it’s already traded 412,000 shares. That’s what it does in a day.

0 · Reply

beachsidefreddy May. 11 at 1:54 PM

$LUNG 216,000 block!!!

0 · Reply

beachsidefreddy May. 11 at 1:47 PM

$LUNG WHEN THE LEVEE BREAKS!!

0 · Reply

beachsidefreddy May. 8 at 7:48 PM

$LUNG THE LEVEE IS BREAKING!!

0 · Reply

dedicatedtoknowledge May. 8 at 4:37 PM

$LUNG I understand APREO running slow this may be Pulmonx doing better

0 · Reply

beachsidefreddy May. 8 at 2:29 PM

$LUNG WHEN THE LEVEE BREAKS

0 · Reply

StMichaelTwits May. 8 at 1:43 PM

$LUNG

0 · Reply

beachsidefreddy May. 7 at 5:29 PM

$LUNG this is the same thing that happened yesterday they tried all day to keep it down and then in the last minute, they just fold their tent the same thing gonna happen today only one of these days it’s gonna be $14 and Jason Kolbert is gonna be a hero

0 · Reply

beachsidefreddy May. 7 at 3:50 PM

$LUNG someone shortly is gonna buy that 10,700 which isn’t real

0 · Reply

Market Cap	54.91M
Revenue (ttm)	90.50M
Net Income (ttm)	-54.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-59.67%
Debt to Equity Ratio	0.81

Volume	282,100
Avg Vol	591,880
Day's Range	N/A - N/A
Shares Out	42.24M
Stochastic %K	41%
Beta	0.18
Analysts	Strong Sell
Price Target	$5.17